MIHÁLY TAPOLYAI, MD, FASN, FACP Associate Professor, Louisiana State University; Shreveport, Louisiana, USA Associate Professor; University of Hawai

Size: px
Start display at page:

Download "MIHÁLY TAPOLYAI, MD, FASN, FACP Associate Professor, Louisiana State University; Shreveport, Louisiana, USA Associate Professor; University of Hawai"

Transcription

1 MIHÁLY TAPOLYAI, MD, FASN, FACP Associate Professor, Louisiana State University; Shreveport, Louisiana, USA Associate Professor; University of Hawai i Postgraduate Training Program at Chubu Hospital, Okinawa, Uruma shi Japan Fresenius Dialysis Center, Semmelweis University, Budapest, Hungary

2

3 Adjusted Relative Risk (RR) of Mortality and Percent of Patients Outside Guideline Target by Practice Pattern

4 Late referral 1 Surgeon s preference and training 2 Patients preference: cosmetic Lack of education 3 High degree of obesity in the population Patient s noncompliance 1 Gibson KD et al Kidney Int June; 59 (6): pp Allon M et al Kidney Int 60 (2001): pp USRDS Wave Annual Data Report:60

5 Infections Vascular stenoses Delay of fistula creation

6 All catheters can get infected Location of temporary catheters do not matter: Subclavian catheters <femoral catheters <jugular catheters Femoral catheters are not more prone to infection

7 In the largest prospective randomized study: the risk of infection was evaluated jugular vs. femoral venous catheterization 750 patients were randomly assigned to jugular or femoral vein catheters The rate of catheter related sepsis was the same with both groups (2.3 versus 1.5 per 1000 catheter days for jugular and femoral venous catheterization, respectively). The risk of catheter colonization at removal did not differ between the femoral and jugular groups (incidence: 40.8 vs 35.7per 1000 catheter days; hazard ratio [HR], 0.85 Among obese patients (BMI >28.4), the incidence of catheter colonization was significantly lower with jugular catheterization, but there was no difference in rates of clinical infection! In addition, hematomas were significantly more common with jugular catheterization (3.6% versus 1.1 %). Parienti JJ; Thirion M; Megarbane B; et al. JAMA May 28;299(20):

8 Parienti JJ; Thirion M; Megarbane B; et al. JAMA May 28;299(20):

9 A prospective study of 105 hemodialysis catheters (79 subclavian, 26 jugular) inserted in 52 patients. 1 Catheter related bacteremia (CRB) was diagnosed in 17 catheters (16%), giving a bacteremia rate of 6.5 episodes per 1000 catheter days. Subgroup analysis revealed a higher risk of CRB with the use of the internal jugular compared with the subclavian site (hazard ratio 3.97, P=0.02). Femoral lines do not have a higher rate of infection. 2 Rate of infection: SUBCLAVIAN < FEMORAL < JUGULAR 1 Kairaitis LK; Gottlieb T Nephrol Dial Transplant 1999 Jul;14(7): Murai DT Chest 2002; 121:

10 Catheters can be salvaged by antibiotics use upto 30% of the time Prospective, observational study 102 patients Marr KA; Sexton DJ; Conlon PJ et al. Ann Intern Med 1997 Aug 15;127(4): Salvage was successful in 66.1% of incident bacteremias with a very low complication risk (0.9%) prospective cohort study 252,986 catheter days, 208 episodes were of bacteremias involving 133 patients Ashby DR; Power A; Singh S et al Clin J Am Soc Nephrol Oct;4(10): Epub 2009 Aug 13. Tunneled Dialysis catheters can be exchanged over a wire; no need for a separate stick The infection free catheter survival is the same (p = 0.72) Retrospective study of 69 patients Kidney Int 2000 May;57(5):

11 Catheters can only be salvaged if: Afebrile after 48 hours of antibiotic therapy Clinically stable No evidence of tunnel tract involvement

12 With subclavian vein catheters (not just dialysis catheters), the incidence of subsequent venous stenosis is approximately 30 to 50 percent Subclavian stenosis occurs 24 to 48 h after catheter removal and 1 mo later Hernandez D; Diaz F; Rufino M et al J Am Soc Nephrol 1998 Aug;9(8): Cimochowski GE; Worley E; Rutherford WE et al Nephron 1990;54(2): Schillinger F; Schillinger D; Montagnac R et al Nephrol Dial Transplant 1991;6(10): Left sided Internal Jugular (IJ) catheters have a high rate of central venous occlusion and twice as high rate of infection as the right IJ Salgado OJ; Urdaneta B; Colmenares B et al Artif Organs Aug;28(8):

13 50% of patients who had a temporary subclavian catheter will have subclavian vein stenosis: That extremity cannot be used for a dialysis access anymore Nephrol Dial Transplant (1988) 3:

14

15

16 High venous pressure Inadequate Kt/V Prolonged bleeding Difficult cannulation Inadequate blood flow Abnormal exam

17 Prospective study of 142 dialysis patients were examined prior to a fistulogram. Then, comparisons were made between physical exam findings and angiography. Sensitivity and specificity for OUTFLOW STENOSIS: 92% and 86% Sensitivity and specificity for INFLOW STENOSIS: 85% and 71% Asif A; Leon C; Orozco Vargas LC et al. Clin J Am Soc Nephrol Nov;2(6): Epub 2007 Oct 10.

18 Controversial subject: Lack of evidence Data are negative when grafts are monitored: Prospective study of 101 patients Clinical criteria for angiography, Qa criteria (<600 ml/min) or stenosis group (all had angiography) Qa monitoring led to higher rate of angiography All three groups had the same 2 year graft survival (60 64% p=0,89) Ram SJ, Work J, Caldito GC, et al. Kidney Int Jul;64(1):

19 5 of 6 randomized clinical trials failed to show a reduction of graft thrombosis in patients undergoing graft surveillance Routine surveillance for graft stenosis, with pre emptive angioplasty, cannot be recommended for reduction of graft thrombosis Data on AVF are even more lacking Allon M, Robbin ML. Hemodial Int Apr;13(2):

20 GUIDELINE 11 Monitoring Primary AV Fistulae for Stenosis Primary AV fistulae should be monitored as outlined for dialysis AV grafts (see Guideline 10: Monitoring Dialysis AV Grafts for Stenosis). (Opinion) Direct flow measurements, if available, are preferable compared to more indirect measures. (Evidence) Methods appropriate for monitoring stenosis in grafts (eg, static and dynamic venous pressures) are not as accurate for monitoring in primary AV fistulae. (Evidence) Recirculation and Doppler analysis are of potential benefit. (Opinion)

21 Inflow problems: pulse augmentation? Outflow problem: venous collapse?

22

23 There should be a continuous, systolic thrill The thrill should be continuous Not only during the systole The thrill should be felt throughout the fistula Normally, the pulse is soft and easily compressible.

24 Inflow The fistula should be soft, compressible and not pulstile When the fistula is compressed in the middle, there pulse should bea pulse on the arterial side: this means there is a good inflow. This is pulse augmentation. If there is no pulse augmentation, the inflow is insufficient. The strength of the pulse is directly proportional to the arterial inflow pressure. This is an arterial problem, it can be angioplastied. This occurs in about 10% of fistula problems.

25 This lesion can be easily diagnosed by palpation of the anastomosis and distal vein Normally, a very prominent thrill is present at the anastomosis. Normally, the pulse is soft and easily compressible. With juxta-anastomotic stenosis, the thrill, which is normally continuous; is present only in systole only. As one moves up the vein from the anastomosis with the palpating finger, the pulse goes away rather abruptly as the site of stenosis is encountered. Above this level, the pulse is very weak and the vein is poorly developed. The stenosis itself can frequently be felt as an abrupt diminution in the size of the vein, almost like a shelf. Juxta-anastomotic stenosis. A radial artery, B stenotic lesion, C cephalic vein.

26 When the extremity is elevated above the head the entire fistula should collapse, at least partially. With a proximal stenosis, the AVF becomes more forcibly pulsatile and firm. It also enlarges rapidly When the extremity is elevated, that portion of the fistula distal to point of stenosis remains distended, while the proximal portion collapses in the normal fashion

27 The type of dialysis access is a major determinnat of outcome on dialysis. Dialysis catheter confer an unacceptible risk. Dialysis fistulas should be maintained and familiarity with the fistula improves its care and maintenance.

Case #1. Case #1- Possible codes. Unraveling the -59 modifier. Principles of Interventional. CASE 1: Simple angioplasty

Case #1. Case #1- Possible codes. Unraveling the -59 modifier. Principles of Interventional. CASE 1: Simple angioplasty Unraveling the -59 modifier Principles of Interventional Coding Donald Schon, MD, FACP Debra Lawson, CPC, PCS Distinct or independent from other services performed on the same day Normally not reported

More information

Postoperative AV Fistula Evaluation. Postoperative examination protocol. Postoperative AVF Protocol. Hemodialysis Access Surveillance

Postoperative AV Fistula Evaluation. Postoperative examination protocol. Postoperative AVF Protocol. Hemodialysis Access Surveillance Hemodialysis Access Surveillance Postoperative AV Fistula Evaluation Failure of maturation Stenosis Perigraft mass/fluid collection Joseph L. Mills, Sr., M.D. Professor of Surgery Chief, Division of Vascular

More information

HD Scanning: Velocities and Volume Flow

HD Scanning: Velocities and Volume Flow HD Scanning: Velocities and Volume Flow Non-Invasive Lab Symposium West Orange, NJ April 27, 2018 Volume Flow Cindy Sturt, MD, FACS, RVT 500,000 Americans on dialysis 20-25% annual mortality 65% 5 year

More information

Why Can't I Cannulate This Fistula? Fistula Immaturity: The Simple But Critical Steps for a Functioning (Mature) AVF

Why Can't I Cannulate This Fistula? Fistula Immaturity: The Simple But Critical Steps for a Functioning (Mature) AVF Why Can t I Cannulate This Access? Steven J. Bander M.D. Adjunct Professor of Nephrology St. Louis University Director, Vascular Access Center, St. Luke s Hospital Saint Louis, MO Why Can't I Cannulate

More information

Introduction to the Native Arteriovenous Fistula: A primer for medical students and radiology residents

Introduction to the Native Arteriovenous Fistula: A primer for medical students and radiology residents Introduction to the Native Arteriovenous Fistula: A primer for medical students and radiology residents Jesus Contreras, D.O. PGY-4 John Yasmer, D.O. Department of Radiology No Disclosures Objectives Introduce

More information

Fistula Maturation Failure. Successful AVF. ASDIN 2014 Scientific Meeting

Fistula Maturation Failure. Successful AVF. ASDIN 2014 Scientific Meeting Fistula First "Unassisted" evaluation of access dysfunction (eyes, ears, and fingers) Tushar Vachharajani, MD Chief, Nephrology Section W. G. (Bill) Hefner VAMC Salisbury, NC Quality improvement projects

More information

Cannulation Techniques Webinar

Cannulation Techniques Webinar Cannulation Techniques Webinar March 28, 2012 ESRD Network of Texas Lynda K. Ball, MSN, RN, CNN Objectives Discuss assessment skills inspection, palpation, and auscultation of an AV fistula to determine

More information

CATHETER REDUCTION. Angelo N. Makris, M.D. Medical Director Chicago Access Care

CATHETER REDUCTION. Angelo N. Makris, M.D. Medical Director Chicago Access Care CATHETER REDUCTION Angelo N. Makris, M.D. Medical Director Chicago Access Care Objectives Discuss tools/techniques proven to improve AVF rates & decrease catheter rates Implement a change process in your

More information

ASDIN 7th Annual Scientific Meeting DISCLOSURES TECHNICAL CONSIDERATIONS TECHNICAL CONSIDERATIONS UTILITY OF ULTRASOUND IN EVALUATING ACCESS

ASDIN 7th Annual Scientific Meeting DISCLOSURES TECHNICAL CONSIDERATIONS TECHNICAL CONSIDERATIONS UTILITY OF ULTRASOUND IN EVALUATING ACCESS DISCLOSURES UTILITY OF ULTRASOUND IN EVALUATING ACCESS DYSFUNCTION None Vandana Dua Niyyar, MD Assistant Professor of Medicine, Division of Nephrology, Emory University UTILITY OF ULTRASOUND IN ACCESS

More information

TheSensitivityandSpecificityofClinicalExaminationoftheHemodialysisArterialVenousFistulaAVFasComparedtoAngiography

TheSensitivityandSpecificityofClinicalExaminationoftheHemodialysisArterialVenousFistulaAVFasComparedtoAngiography : F Diseases Volume 16 Issue 3 Version 1.0 Year 2016 Type: Double Blind Peer Reviewed International Research Journal Publisher: Global Journals Inc. (USA) Online ISSN: 2249-4618 & Print ISSN: 0975-5888

More information

Guidelines for Arteriovenous Access Intervention, Management and Abandonment, and for Removal of Pre- Study Dialysis Catheter

Guidelines for Arteriovenous Access Intervention, Management and Abandonment, and for Removal of Pre- Study Dialysis Catheter Guidelines for Arteriovenous Access Intervention, Management and Abandonment, and for Removal of Pre- Study Dialysis Catheter The guidelines for arteriovenous access intervention, management and abandonment,

More information

AMMAR SERAWAN, MD. Ain Wzain Hospital. April 21, 2012 Vascular Access Study Workshop

AMMAR SERAWAN, MD. Ain Wzain Hospital. April 21, 2012 Vascular Access Study Workshop AMMAR SERAWAN, MD Ain Wzain Hospital April 21, 2012 Vascular Access Study Workshop 1 Inspection for signs of: - infection (redness, discharge, edema) -aneurysms (may be cannulated using the lateral side

More information

Distal Hypoperfusion Ischemic Syndrome (DHIS)

Distal Hypoperfusion Ischemic Syndrome (DHIS) Pathophysiology Traditional View ( Steal Syndrome ) Distal Hypoperfusion Ischemic Syndrome (DHIS) Steven Wu, MD Director of Interventional Nephrology Massachusetts General Hospital Harvard Medical School

More information

St George Hospital Renal Department Internal Policy

St George Hospital Renal Department Internal Policy COMPLICATIONS OF VASCULAR ACCESS FOR HAEMODIALYSIS. SUMMARY: Any type of complication for either a centrally placed venous catheter or arterio-venous fistula/graft can place the patient at risk of sub-optimal

More information

Medical Director/Surgeon as Partners WebEx February 11, 2010

Medical Director/Surgeon as Partners WebEx February 11, 2010 Medical Director/Surgeon as Partners WebEx February 11, 2010 Over 400,000 patients are treated yearly for ESRD in the USA; 60% of these patients receive some form of hemodialysis Despite major advances

More information

Juxta-anastomotic stenoses: angioplasty or surgery (or when/why should we wait)?

Juxta-anastomotic stenoses: angioplasty or surgery (or when/why should we wait)? Juxta-anastomotic stenoses: angioplasty or surgery (or when/why should we wait)? Richard Shoenfeld MD, FSIR, FAHA The Access Center at West Orange West Orange, New Jersey USA SEDAV 2015 Madrid November

More information

Jimmy Wei Hwa Tan, Surg, MD

Jimmy Wei Hwa Tan, Surg, MD Jimmy Wei Hwa Tan, Surg, MD Director, Department of Surgery Chief, Department of Cardiovascular Surgery Tainan An-Nan Municipal Hospital, China Medical University, Taiwan Disclosure I have the following

More information

Case Endovascular management of non maturing dyalisis vascular access

Case Endovascular management of non maturing dyalisis vascular access Case 10238 Endovascular management of non maturing dyalisis vascular access Guedes Pinto 1, Erique; Madeira 2, Célia; Sousa 3, Marta; Penha 1, Diana; Rosa 1, Luís; Germano 1, Ana; Baptista 1, Manuela 1

More information

Does cannulation technique impact arteriovenous fistula and graft survival? Maria Teresa Parisotto CANNT 2017 Halifax October 20 th, 2017

Does cannulation technique impact arteriovenous fistula and graft survival? Maria Teresa Parisotto CANNT 2017 Halifax October 20 th, 2017 Does cannulation technique impact arteriovenous fistula and graft survival? Maria Teresa Parisotto CANNT 2017 Halifax October 20 th, 2017 Survival Preserving the AVF as the patient lifeline: reduced mortality

More information

Ruolo della clinica e del laboratorio nella diagnosi di malfunzionamento di una FAV

Ruolo della clinica e del laboratorio nella diagnosi di malfunzionamento di una FAV Ruolo della clinica e del laboratorio nella diagnosi di malfunzionamento di una FAV Carlo Basile Division of Nephrology and Dialysis Miulli General Hospital, Acquaviva delle Fonti, Italy VASCULAR ACCESS

More information

ASDIN 7th Annual Scientific Meeting

ASDIN 7th Annual Scientific Meeting Strategies for Decreasing the Use of Hemodialysis Catheters ASDIN 7 th Annual Scientific Meeting Outline Late referral Primary failure Why Not PD? Summary Micah Chan MD MPH FACP Assistant Professor of

More information

Explorations fonctionnelles des abords vasculaires pour hémodialyse

Explorations fonctionnelles des abords vasculaires pour hémodialyse Explorations fonctionnelles des abords vasculaires pour hémodialyse Frank Le Roy Nephrology Department Actualités Néphrologiques Jean Hamburger Necker, 27 avril 2015 1966 Brescia, Cimino, Appel, Hurwich.

More information

AV ACESS COMPLICATIONS. Ass. Prof. Dr. Habas

AV ACESS COMPLICATIONS. Ass. Prof. Dr. Habas AV ACESS COMPLICATIONS Ass. Prof. Dr. Habas COMPLICATION AVF IS CONSIDERED A MINOR PROCEDURE INCIDENCE OF COMPLICATION- 20-27% MANY A COMPLICATION LEADS TO FAILURE OF FISTULA LOSS OF SITE AND VEIN FOR

More information

Assessment, Monitoring, and. Svetlana (Lana) Kacherova, ESRD Network 18, QI Director WebEx session, December 18, 2008

Assessment, Monitoring, and. Svetlana (Lana) Kacherova, ESRD Network 18, QI Director WebEx session, December 18, 2008 Vascular Access Assessment, Monitoring, and Surveillance Svetlana (Lana) Kacherova, ESRD Network 18, QI Director WebEx session, December 18, 2008 1 Special Acknowledgement for Content Contributions: RMS

More information

AVF Prevalence. Local elastase to aid fistula maturation. I have nothing to disclose

AVF Prevalence. Local elastase to aid fistula maturation. I have nothing to disclose Local elastase to aid fistula maturation Warren Gasper MD UCSF Vascular Surgery Fellow 2013 UCSF Vascular Symposium I have nothing to disclose AVF Prevalence 60.6% (April 2012) Fistula First Initiative

More information

Selection of Permanent Hemodialysis Vascular Access

Selection of Permanent Hemodialysis Vascular Access Selection of Permanent Hemodialysis Vascular Access TABLE OF CONTENTS 1.0 Scope...1 2.0 Recommendations & Rationale... 2 3.0 References... 3 4.0 Sponsors... 9 5.0 Effective Date... 10 Appendix 1: Key Elements

More information

VA Session: A Team-Based Approach to Solving Vascular Access Problems. October 7, 2016

VA Session: A Team-Based Approach to Solving Vascular Access Problems. October 7, 2016 2016 VA Session: A Team-Based Approach to Solving Vascular Access Problems October 7, 2016 Panel discussion with: Dr. Mercedeh Kiaii (nephrologist) Dr. Jerry Chen (surgeon) Mirita Zerr (vascular access

More information

Decreased Incidence of Clotted AV Access in Hemodialysis Patients after the Implementation of Follow up Program

Decreased Incidence of Clotted AV Access in Hemodialysis Patients after the Implementation of Follow up Program Global Journal of Health Science; Vol. 8, No. 10; 2016 ISSN 1916-9736 E-ISSN 1916-9744 Published by Canadian Center of Science and Education Decreased Incidence of Clotted AV Access in Hemodialysis Patients

More information

4/29/2012. Management of Central Vein Stenoses. Central Venous Stenoses and Occlusions

4/29/2012. Management of Central Vein Stenoses. Central Venous Stenoses and Occlusions Central Venous Stenoses and Occlusions Management of Central Vein Stenoses Robert K. Kerlan Jr. M.D. Professor of Clinical Radiology and Surgery University of California San Francisco Key Questions What

More information

III. NKF-K/DOQI CLINICAL PRACTICE GUIDELINES FOR VASCULAR ACCESS: UPDATE 2000

III. NKF-K/DOQI CLINICAL PRACTICE GUIDELINES FOR VASCULAR ACCESS: UPDATE 2000 III. NKF-K/DOQI CLINICAL PRACTICE GUIDELINES FOR VASCULAR ACCESS: UPDATE 2000 NOTE: The citation for these guidelines should read as follows: National Kidney Foundation. K/DOQI Clinical Practice Guidelines

More information

Sid Bhende MD Sentara Vascular Specialists April 28 th Dialysis Access Review: Understanding the Access Options our Patients Face

Sid Bhende MD Sentara Vascular Specialists April 28 th Dialysis Access Review: Understanding the Access Options our Patients Face Sid Bhende MD Sentara Vascular Specialists April 28 th 2018 Dialysis Access Review: Understanding the Access Options our Patients Face Disclosures Dialysis Background Why is it important? Outline National

More information

Percutaneous transluminal angioplasty in the treatment of stenosis of hemodialysis arteriovenous fistulae: our experience

Percutaneous transluminal angioplasty in the treatment of stenosis of hemodialysis arteriovenous fistulae: our experience Percutaneous transluminal angioplasty in the treatment of stenosis of hemodialysis arteriovenous fistulae: our experience Poster No.: C-3355 Congress: ECR 2010 Type: Scientific Exhibit Topic: Interventional

More information

Evaluation of AVF and AVG

Evaluation of AVF and AVG Evaluation of AVF and AVG 2013 Nephrology Nursing Symposium Albuquerque Vascular Access Leading cause of hospitalization in the ESRD population Annual cost approaching $1.5 billion (USRDS, 2004) Current

More information

Department of Vascular Surgery, Maastricht University, Maastricht - The Netherlands 2

Department of Vascular Surgery, Maastricht University, Maastricht - The Netherlands 2 The Journal of Vascular Access 2007; 8: 281-286 ORIGINAL ARTICLE Accessory veins and radial-cephalic arteriovenous fistula non-maturation: a prospective analysis using contrast-enhanced magnetic resonance

More information

Sichol sooksee,rn. Hemodialysis Unit Rajavej Chiang Mai Hospital

Sichol sooksee,rn. Hemodialysis Unit Rajavej Chiang Mai Hospital Sichol sooksee,rn. Hemodialysis Unit Rajavej Chiang Mai Hospital Button hole or Ladder?? Vascular Access Cannulation It s a Life Line of Hemodialysis patient Arterio-venous fistula(avf) is the K/DOQI

More information

UC SF. End Stage Renal Disease. National Kidney Foundation Dialysis Outcomes Quality Initiative (K/DOQI) BUT-- No Cephalic Vein What s Next

UC SF. End Stage Renal Disease. National Kidney Foundation Dialysis Outcomes Quality Initiative (K/DOQI) BUT-- No Cephalic Vein What s Next No Cephalic Vein What s Next End Stage Renal Disease Charles Eichler MD Clinical Professor of Surgery Division of Vascular Surgery UCSF April 5, 2014 Population of patients with ESRD growing rapidly -

More information

NON-MATURED ARTERIOVENOUS FISTULAE FOR HAEMODIALYSIS: DIAGNOSIS, ENDOVASCULAR AND SURGICAL TREATMENT

NON-MATURED ARTERIOVENOUS FISTULAE FOR HAEMODIALYSIS: DIAGNOSIS, ENDOVASCULAR AND SURGICAL TREATMENT & NON-MATURED ARTERIOVENOUS FISTULAE FOR HAEMODIALYSIS: DIAGNOSIS, ENDOVASCULAR AND SURGICAL TREATMENT Marko Malovrh* Department of Nephrology, University Medical Centre Ljubljana, Zaloška 7, 1525 Ljubljana,

More information

Technical and Clinical Barriers to Implementing an Optimal Case Mix of Vascular Access

Technical and Clinical Barriers to Implementing an Optimal Case Mix of Vascular Access Technical and Clinical Barriers to Implementing an Optimal Case Mix of Vascular Access Louise Moist Associate Professor Lead Vascular Access Ontario Renal Network Schulich School of Medicine University

More information

Sonographic Evaluation of an Immature Brescia-Cimino Fistula

Sonographic Evaluation of an Immature Brescia-Cimino Fistula 696792JDMXXX10.1177/8756479317696792Journal of Diagnostic Medical SonographyChappell research-article2017 Case Study Sonographic Evaluation of an Immature Brescia-Cimino Fistula Journal of Diagnostic Medical

More information

Preservation of Veins and Timing for Vascular Access

Preservation of Veins and Timing for Vascular Access Preservation of Veins and Timing for Vascular Access Vassilis Liakopoulos, MD, PhD Department of Nephrology School of Medicine University of Thessaly Greece Hemodialysis VA A sound long-term dialysis access

More information

Arteriovenous fistula cannulation by buttonhole technique using dull needle

Arteriovenous fistula cannulation by buttonhole technique using dull needle Original Article Arteriovenous fistula cannulation by buttonhole technique using dull needle Authors Manuel Carlos Martins de Castro 1 Celina de Fátima e Silva 1 João Marcos Rodrigues de Souza 1 Maria

More information

Arterial Access for Diagnosis and Intervention T-Woei Tan, MD, FACS

Arterial Access for Diagnosis and Intervention T-Woei Tan, MD, FACS Arterial Access for Diagnosis and Intervention T-Woei Tan, MD, FACS Assistant Professor of Surgery Vascular Endovascular Surgery Louisiana State University Health - Shreveport Disclosures None Objective

More information

The HeRO Graft. Shawn M. Gage, PA Division of Vascular Surgery Duke University Medical Center

The HeRO Graft. Shawn M. Gage, PA Division of Vascular Surgery Duke University Medical Center The HeRO Graft Shawn M. Gage, PA Division of Vascular Surgery Duke University Medical Center Faculty Disclosure I disclose the following financial relationships: CryoLife/Hemosphere, Inc. & W.L. Gore and

More information

Bare Metal Stents vs Stent Grafts

Bare Metal Stents vs Stent Grafts Bare Metal Stents vs Stent Grafts ASDIN 12th Annual Scientific Meeting Phoenix, AZ, February 20, 2016 Dirk Hentschel, MD Director, Interventional Nephrology Brigham and Women s Hospital Disclosure Consultant:

More information

HEMODIALYSIS. Nursing 246 Adapted from Lewis Chapter 47 Donna Geiger, RN, MSN, FNP

HEMODIALYSIS. Nursing 246 Adapted from Lewis Chapter 47 Donna Geiger, RN, MSN, FNP HEMODIALYSIS Nursing 246 Adapted from Lewis Chapter 47 Donna Geiger, RN, MSN, FNP Dialysis Begun when patient s uremia can no longer be adequately managed conservatively What is uremia?? What lab test

More information

What s on the Horizon in Dialysis Access? Libby Watch, MD, FACS Miami Cardiac & Vascular Institute

What s on the Horizon in Dialysis Access? Libby Watch, MD, FACS Miami Cardiac & Vascular Institute What s on the Horizon in Dialysis Access? Libby Watch, MD, FACS Miami Cardiac & Vascular Institute Disclosures No relevant disclosures Employee Advanced Access Care Dialysis Work 5 operating surgeons 3

More information

Prospective, randomized controlled study of paclitaxel-coated versus plain balloon angioplasty for the treatment of failing dialysis access

Prospective, randomized controlled study of paclitaxel-coated versus plain balloon angioplasty for the treatment of failing dialysis access Prospective, randomized controlled study of paclitaxel-coated versus plain balloon angioplasty for the treatment of failing dialysis access Disclosure Speaker name:... I have the following potential conflicts

More information

Vascular a ccess access for Dialysis a surgeon s perspecti e v. some observations

Vascular a ccess access for Dialysis a surgeon s perspecti e v. some observations Vascular access for Dialysis a surgeon s perspective e. some observations Age of New Haemodialysis Patients 2005 Australia Number (Total=1957) 0.7% 3% 5% 10% 15% 20% 26% 19% 2% 0-14 15-24 25-34 35-44

More information

LUTONIX AV Clinical Trial

LUTONIX AV Clinical Trial LUTONIX AV Clinical Trial A Prospective, Global, Multicenter, Randomized, Controlled Study Comparing LUTONIX 035 AV Drug Coated Balloon PTA Catheter vs. Standard Balloon PTA Catheter for the Treatment

More information

Fistula/Graft Protection. Leslie Dork Renal Medicine Associates

Fistula/Graft Protection. Leslie Dork Renal Medicine Associates + Fistula/Graft Protection Leslie Dork Renal Medicine Associates + Disclaimer Renal Medicine Associates employee I have no conflicts of interest. + Access failure Infections Infiltrations Stenoses/Thrombosis

More information

Safety of arteriovenous fistulae and grafts for continuous renal replacement therapy: The Michigan experience

Safety of arteriovenous fistulae and grafts for continuous renal replacement therapy: The Michigan experience Hemodialysis International 2018; 22:50 55 Original Article Access Safety of arteriovenous fistulae and grafts for continuous renal replacement therapy: The Michigan experience Anas AL RIFAI, 1,2 Nidhi

More information

Review Article Duplex Ultrasound Evaluation of Hemodialysis Access: A Detailed Protocol

Review Article Duplex Ultrasound Evaluation of Hemodialysis Access: A Detailed Protocol International Nephrology Volume 2012, Article ID 508956, 7 pages doi:10.1155/2012/508956 Review Article Duplex Ultrasound Evaluation of Hemodialysis Access: A Detailed Protocol Victoria Teodorescu, 1,

More information

Cardiovascular Comorbidity and Late Referral Impact Arteriovenous Fistula Survival: A Prospective Multicenter Study

Cardiovascular Comorbidity and Late Referral Impact Arteriovenous Fistula Survival: A Prospective Multicenter Study J Am Soc Nephrol 15: 204 209, 2004 Cardiovascular Comorbidity and Late Referral Impact Arteriovenous Fistula Survival: A Prospective Multicenter Study PIETRO RAVANI,* GIULIANO BRUNORI, SALVATORE MANDOLFO,

More information

What vascular access for which patient : obesity

What vascular access for which patient : obesity What vascular access for which patient : obesity C. Sessa, J. Coudurier A. De Lambert, C. Ducos, M. Guergour, O. Pichot Department of Vascular Surgery Grenoble France Controversies & Updates in Vascular

More information

Occlusion: A New Technique Antegrade wiring i with retrograde ballooning and stenting

Occlusion: A New Technique Antegrade wiring i with retrograde ballooning and stenting How To Treat Resistant Central Venous Occlusion: A New Technique Antegrade wiring i with retrograde ballooning and stenting Dafsah A Juzar T. Santoso National Heart Center, Harapan Kita, & Medistra Hospital

More information

Percutaneous AV Fistula Creation. Ellipsys EndoAVF System

Percutaneous AV Fistula Creation. Ellipsys EndoAVF System Percutaneous AV Fistula Creation Ellipsys EndoAVF System Presented by Forest Rawls Jr CHT,CCHT-A,FNKF No Disclosures Various Access Types Some old Some new Scribner Shunt OUR OLD DEPENDABLE FRIEND

More information

Vascular Surgery Cases: Detours. Brian F. Stull, RDMS, RVT UNC REX Healthcare Vascular Specialists

Vascular Surgery Cases: Detours. Brian F. Stull, RDMS, RVT UNC REX Healthcare Vascular Specialists Vascular Surgery Cases: Detours Brian F. Stull, RDMS, RVT UNC REX Healthcare Vascular Specialists Brian.Stull@Unchealth.unc.edu Objectives Anatomy of a bypass graft Where does it connect, where does it

More information

CSI (Clinical Scenario Investigation): Hyperkalemia

CSI (Clinical Scenario Investigation): Hyperkalemia CSI (Clinical Scenario Investigation): Hyperkalemia Alison Thomas, RN(EC), MN, CNeph(C) Ann Jones, RN(EC), MSN, CNeph(C) Joyce Hunter, RN, Vascular Access Co-ordinator Simcoe Muskoka Regional Kidney Care

More information

COVERA Vascular Covered Stents in the Management of Dysfunctional AV Access

COVERA Vascular Covered Stents in the Management of Dysfunctional AV Access COVERA Vascular Covered Stents in the Management of Dysfunctional AV Access Bart L. Dolmatch, M.D., FSIR Palo Alto Medical Foundation Mountain View, CA USA This presentation is being made on behalf of

More information

Inflow stenosis in arteriovenous fistulas and grafts: A multicenter, prospective study

Inflow stenosis in arteriovenous fistulas and grafts: A multicenter, prospective study Kidney International, Vol. 67 (2005), pp. 1986 1992 Inflow stenosis in arteriovenous fistulas and grafts: A multicenter, prospective study ARIFASIF, FLORIN N. GADALEAN, DONNA MERRILL, GAUTAM CHERLA, CRISTIAN

More information

KDOQI Guidelines. Overview. Predicting Successful Fistula Maturation Warren Gasper MD UCSF Vascular Surgery Fellow 2011 UCSF Vascular Symposium

KDOQI Guidelines. Overview. Predicting Successful Fistula Maturation Warren Gasper MD UCSF Vascular Surgery Fellow 2011 UCSF Vascular Symposium DISCLOSURES: NONE Predicting Successful Fistula Maturation Warren Gasper MD UCSF Vascular Surgery Fellow 2011 UCSF Vascular Symposium KDOQI Guidelines AV fistulas have better outcomes than grafts or catheters

More information

Outcome of a comprehensive follow-up program to enhance maturation of autogenous arteriovenous hemodialysis access

Outcome of a comprehensive follow-up program to enhance maturation of autogenous arteriovenous hemodialysis access From the Society for Clinical Vascular Surgery Outcome of a comprehensive follow-up program to enhance maturation of autogenous arteriovenous hemodialysis access Robert B. McLafferty, MD, Raymond W. Pryor

More information

First experience with DCB for treatment of dialysis access stenosis The Greek experience

First experience with DCB for treatment of dialysis access stenosis The Greek experience First experience with DCB for treatment of dialysis access stenosis The Greek experience D Karnabatidis Department of Interventional Radiology Patras University Hospital Patras, Greece Background Vessel

More information

PROVINCIAL STANDARDS & GUIDELINES

PROVINCIAL STANDARDS & GUIDELINES PROVINCIAL STANDARDS & GUIDELINES Insertion and Removal of Tunneled Hemodialysis Catheters Reviewed May 2017 Developed by the BCPRA Hemodialysis Committee Table of Contents 1.0 Scope... 1 2.0 Recommendations...

More information

Evaluation of percutaneous transluminal angioplasty screening using color Doppler ultrasonography

Evaluation of percutaneous transluminal angioplasty screening using color Doppler ultrasonography Evaluation of percutaneous transluminal angioplasty screening using color Doppler ultrasonography Keiji Tabuchi,2, Toshio Kobayashi 2, Junko Kumagai 3, Naoko Takahashi 3 ) Departments of Nursing, Omachi

More information

ASDIN 9th Annual Scientific Meeting

ASDIN 9th Annual Scientific Meeting Stent Graft Placement is Best for Cephalic Arch and Central Vein Stenosis Dheeraj K. Rajan MD, FRCPC, FSIR Head - Division of Vascular and Interventional Radiology University of Toronto University Health

More information

Dr. Murty Mantha MD FRACP Cairns Base Hospital Cairns. DNT 2011 Hunter Valley

Dr. Murty Mantha MD FRACP Cairns Base Hospital Cairns. DNT 2011 Hunter Valley Dr. Murty Mantha MD FRACP Cairns Base Hospital Cairns DNT 2011 Hunter Valley Approximately 45% of AVF are functional without intervention after creation The procedure rate is 1.45-3.3 procedures/avf

More information

Introduction. Introduction 2/18/2015 ASDIN Vascular Access complications: High associated morbi-mortality. Worsened quality of life

Introduction. Introduction 2/18/2015 ASDIN Vascular Access complications: High associated morbi-mortality. Worsened quality of life Introduction Vascular Access complications: Ultrasound Evaluation of the Mature AVF and Process Improvement High associated morbi-mortality Worsened quality of life Up to 25 % hospitalized Jose Ibeas M.D.,

More information

AV Access Technology and Innovation DEVICES CHANGING HOW WE THINK ABOUT VASCULAR ACCESS

AV Access Technology and Innovation DEVICES CHANGING HOW WE THINK ABOUT VASCULAR ACCESS AV Access Technology and Innovation DEVICES CHANGING HOW WE THINK ABOUT VASCULAR ACCESS Vascular Access New Technology What problem are you trying to solve for? Most common problem is inadequate outflow

More information

A New Technique to Superficialize Arteriovenous Fistulas Too Deep for Reliable Cannulation

A New Technique to Superficialize Arteriovenous Fistulas Too Deep for Reliable Cannulation A New Technique to Superficialize Arteriovenous Fistulas Too Deep for Reliable Cannulation Danielle Fontenot, MD, MS Adam Tanious, MD, MMSc, Yusuf Chauhan, BS Alicia Stafford, BS, Karl A. Illig, MD University

More information

MANITOBA RENAL PROGRAM

MANITOBA RENAL PROGRAM SUBJECT Venipuncture of Arteriovenous Fistula/Graft MANITOBA RENAL PROGRAM SECTION CODE 30.20.01 30.20 Vascular Access AUTHORIZATION Professional Advisory Committee, Manitoba Renal Program Nursing Practice

More information

IN.PACT AV Access IDE Study Full Baseline Data. Robert Lookstein, MD MHCDL New York, NY On Behalf of the IN.PACT AV ACCESS Investigators

IN.PACT AV Access IDE Study Full Baseline Data. Robert Lookstein, MD MHCDL New York, NY On Behalf of the IN.PACT AV ACCESS Investigators IN.PACT AV Access IDE Study Full Baseline Data Robert Lookstein, MD MHCDL New York, NY On Behalf of the IN.PACT AV ACCESS Investigators Disclosures Speaker name: Robert Lookstein, MD... I have the following

More information

Victoria Chapman BS, RN, HP (ASCP)

Victoria Chapman BS, RN, HP (ASCP) Victoria Chapman BS, RN, HP (ASCP) Considerations: Age Sex Body Composition Hydration Status Chemotherapy Use Access History Considerations: Immunosuppression Use Chemotherapy Frequency of plasma exchanges

More information

Supera for the Juxta-anastomotic AVF Stenosis

Supera for the Juxta-anastomotic AVF Stenosis Supera for the Juxta-anastomotic AVF Stenosis Dr Shannon D. Thomas Vascular Access Surgeon Conjoint Senior Lecturer University of New South Wales Sydney, Australia Disclosure Speaker name: Dr S. D. Thomas...

More information

Steal Syndrome: The Role of the Vascular Lab

Steal Syndrome: The Role of the Vascular Lab Steal Syndrome: The Role of the Vascular Lab Eighth Overlook Noninvasive Vascular Lab Symposium Larry A. Scher, M.D. Professor of Surgery Division of Vascular Surgery Montefiore Medical Center Albert Einstein

More information

Goals. Access flow and renal artery stenosis evaluation by Doppler ultrasound. Reimbursement. WHY use of Doppler Ultrasound

Goals. Access flow and renal artery stenosis evaluation by Doppler ultrasound. Reimbursement. WHY use of Doppler Ultrasound Access flow and renal artery stenosis evaluation by Doppler ultrasound Adina Voiculescu, MD Interventional Nephrology Brigham and Women s Hospital Boston Instructor at Harvard Medical School Understand

More information

UPDATE IN VASCULAR ACCESS Mercedeh Kiaii MD FRCPC Rick Luscombe RN BSN CNeph(C) Elizabeth Lee MD FRCPC

UPDATE IN VASCULAR ACCESS Mercedeh Kiaii MD FRCPC Rick Luscombe RN BSN CNeph(C) Elizabeth Lee MD FRCPC UPDATE IN VASCULAR ACCESS Mercedeh Kiaii MD FRCPC Rick Luscombe RN BSN CNeph(C) Elizabeth Lee MD FRCPC Background Endovascular AVF Outline Data from FLEX and NEAT study SPH data Clinical experience Cannulation

More information

The Role of LUTONIX 035 DCB in AV Fistula Dysfunction Management in our Practice

The Role of LUTONIX 035 DCB in AV Fistula Dysfunction Management in our Practice The Role of LUTONIX 035 DCB in AV Fistula Dysfunction Management in our Practice Dr Kate Steiner Consultant Interventional Radiologist East and North Hertfordshire NHS Trust Disclosure Speaker name: Dr

More information

Cardiovascular Implantable Electronic Device Leads & Arteriovenous Hemodialysis Access

Cardiovascular Implantable Electronic Device Leads & Arteriovenous Hemodialysis Access Cardiovascular Implantable Electronic Device Leads & Arteriovenous Hemodialysis Access Theodore F. Saad, MD Nephrology Associates, PA Christiana Care Health System Newark, Delaware Cardiovascular Implantable

More information

7/7/2015. Objectives. Pros and Cons of Buttonhole Cannulation

7/7/2015. Objectives. Pros and Cons of Buttonhole Cannulation Objectives Pros and Cons of Buttonhole Cannulation Charmaine Lok, MD, FRCPC, MSc University of Toronto Toronto General Hospital To gain an appreciation of the importance of proper vascular access cannulation

More information

End Stage Renal Disease (ESRD) Network Learning and Action Network (LAN) Series: Bloodstream Infection (BSI) Quality Improvement Activity

End Stage Renal Disease (ESRD) Network Learning and Action Network (LAN) Series: Bloodstream Infection (BSI) Quality Improvement Activity End Stage Renal Disease (ESRD) Network Learning and Action Network (LAN) Series: Bloodstream Infection (BSI) Quality Improvement Activity October 2, 2018 Note: Computer speakers or headphones are necessary

More information

Brachial vein transposition arteriovenous fistulas for hemodialysis access

Brachial vein transposition arteriovenous fistulas for hemodialysis access From the Society for Vascular Surgery Brachial vein transposition arteriovenous fistulas for hemodialysis access William C. Jennings, MD, Matthew J. Sideman, MD, Kevin E. Taubman, MD, and Thomas A. Broughan,

More information

ASDIN 7th Annual Scientific Meeting

ASDIN 7th Annual Scientific Meeting Reported incidence 1-20% Loay Salman, MD Assistant Professor of Medicine University of Miami Miller School of Medicine Tordoir et al. J Vasc Endovasc Sur. 2004 Morsy et al. J Surg Res. 1998 Haimov et al.

More information

Interventions for AV-Shunt stenosis: What works best PTA, Stent or DCB?

Interventions for AV-Shunt stenosis: What works best PTA, Stent or DCB? Interventions for AV-Shunt stenosis: What works best PTA, Stent or DCB? Martin Forlee Vascular Surgeon Cape Town Disclosure Speaker name: Martin Forlee I have the following potential conflicts of interest

More information

IN-CENTER HEMODIALYSIS (HD) CLINICAL PERFORMANCE MEASURES DATA COLLECTION FORM 2006

IN-CENTER HEMODIALYSIS (HD) CLINICAL PERFORMANCE MEASURES DATA COLLECTION FORM 2006 IN-CENTER HEMODIALYSIS (HD) CLINICAL PERFORMANCE MEASURES DATA COLLECTION FORM 2006 PATIENT IDENTIFICATION [Before completing please read instructions at the bottom of this page and on pages 5 and 6] MAKE

More information

Dialysis Overview S J Fratesi MD FRCS

Dialysis Overview S J Fratesi MD FRCS Dialysis Overview 2005 S J Fratesi MD FRCS By the end of this session you should have an better understanding of : Ø Ø Ø Ø Ø Ø Ø Ø concept of dialysis alternative methods of dialysis indications for hemodialysis

More information

No Place Like ehome. Anna Gozdzik. Contributors: Zita Abreu Jovina Bachynski Cyndi Bhola

No Place Like ehome. Anna Gozdzik. Contributors: Zita Abreu Jovina Bachynski Cyndi Bhola No Place Like ehome Anna Gozdzik Contributors: Zita Abreu Jovina Bachynski Cyndi Bhola ENABLE HOME OPTIMIZATION, MANAGEMENT AND EDUCATION Objectives Principle of shared decision-making Evolution of ehome

More information

HeRO. Jeffrey H. Lawson, M.D., Ph.D. Departments of Surgery and Pathology Duke University Medical Center Durham, North Carolina

HeRO. Jeffrey H. Lawson, M.D., Ph.D. Departments of Surgery and Pathology Duke University Medical Center Durham, North Carolina HeRO Jeffrey H. Lawson, M.D., Ph.D. Departments of Surgery and Pathology Duke University Medical Center Durham, North Carolina Disclosures Consulting, Clinical Trials and Opinion Hemosphere Ark Therapeutics

More information

2006 NKF-DOQI Guidelines Preferred Vascular Access Order 1. Radiocephalic (wrist) fistula 2. Brachiocephalic (elbow) fistula 3. Basilic vein transposi

2006 NKF-DOQI Guidelines Preferred Vascular Access Order 1. Radiocephalic (wrist) fistula 2. Brachiocephalic (elbow) fistula 3. Basilic vein transposi Stage 5 Chronic Kidney Disease Assessing the Results of AV Access: Realistic Outcomes in 2009 Sean P. Roddy, MD Albany, NY Defined as a GFR

More information

Tale of Neglected Aneurysm

Tale of Neglected Aneurysm Disclosures Tale of Neglected Aneurysm Consultant to FFCL Tushar Vachharajani, MD, FASN Chief, Nephrology Section Salisbury VAMC, NC Objectives How do you define Aneurysm? When and How do you treat? Defining

More information

( GFR 30 ml/min/1.73m 2 ) [2] (Tunneled cuffed catheter) [1] [3]

( GFR 30 ml/min/1.73m 2 ) [2] (Tunneled cuffed catheter) [1] [3] [1] 07-3422121-2045 E-mail: cyhsu@vghks.gov.tw ( GFR 30 ml/min/1.73m 2 ) [2] (fistula) (graft) (Tunneled cuffed catheter) [3] 97 20 2 63 Allen s test (Duplex doppler ultrasound) [4] 2.0 mm2.5 mm [5] ()

More information

NKF K/DOQI GUIDELINES

NKF K/DOQI GUIDELINES NKF K/DOQI GUIDELINES Executive Summaries Anemia Hemodialysis Peritoneal Dialysis Vascular Access Nutrition CKD 2002 Dyslipidemias Bone Metabolism Hypertension and Antihypertensive Agents Cardiovascular

More information

Ultrasound and the dialysis patient

Ultrasound and the dialysis patient Ultrasound and the dialysis patient Poster No.: C-1765 Congress: ECR 2011 Type: Educational Exhibit Authors: T. M. O. Couto, H. Matos, Â. Moreira, A. Estevao ; vila conde/ 1 2 2 2 1 2, Coimbra/ Keywords:

More information

Superficialización de la vena basílica. Pierre BOURQUELOT, Paris

Superficialización de la vena basílica. Pierre BOURQUELOT, Paris Superficialización de la vena basílica. Pierre BOURQUELOT, Paris 1 Basilic Vein Superficialization. Pierre BOURQUELOT, Paris 2 (Upper arm) Basilic Vein 3 Technique 2-stage Basilic Vein Tunnel-Superficialization

More information

PREVENTION AND TREATMENT OF ANEURYSMS OF AUTOGENOUS DIALYSIS ACCESSES STEPHEN L. HILL, M.D.,F.A.C.S

PREVENTION AND TREATMENT OF ANEURYSMS OF AUTOGENOUS DIALYSIS ACCESSES STEPHEN L. HILL, M.D.,F.A.C.S PREVENTION AND TREATMENT OF ANEURYSMS OF AUTOGENOUS DIALYSIS ACCESSES STEPHEN L. HILL, M.D.,F.A.C.S THE INCREASE IN THE CONSTRUCTION OF AUTOGENOUS FISTULAE OVER THE PAST TEN YEARS HAS BROUGHT WITH IT 1.

More information

Doppler Ultrasound: is it a third generation AVF surveillance method?

Doppler Ultrasound: is it a third generation AVF surveillance method? Doppler Ultrasound: is it a third generation AVF surveillance method? Jose Ibeas. Servei de Nefrologia Parc Tauli Sabadell, Hospital Universitari Barcelona Disclosures I have the following potential conflicts

More information

Evaluation of hemodialysis arteriovenous fistula before and after surgery: Teaching points

Evaluation of hemodialysis arteriovenous fistula before and after surgery: Teaching points Evaluation of hemodialysis arteriovenous fistula before and after surgery: Teaching points Poster No.: C-0625 Congress: ECR 2014 Type: Educational Exhibit Authors: L. C. C. Chierighini, P. C. Francolin,

More information

Combat Extremity Vascular Trauma

Combat Extremity Vascular Trauma Combat Extremity Vascular Trauma Training teams to be a TEAM Chatt A. Johnson LTC, MC, USA 08 March 2010 US Army Trauma Training Center Core Discussion Series Outline: Combat Vascular Injury Physiologic

More information

MANITOBA RENAL PROGRAM

MANITOBA RENAL PROGRAM SUBJECT Venipuncture of Arteriovenous Fistula/Graft MANITOBA RENAL PROGRAM SECTION CODE 30.30.01 30.30 Vascular Access AUTHORIZATION Professional Advisory Committee, Manitoba Renal Program Nursing Practice

More information